Page last updated: 2024-10-20

uracil and Dermatitis, Atopic

uracil has been researched along with Dermatitis, Atopic in 4 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research Excerpts

ExcerptRelevanceReference
" In addition, compound 13d, having potent hydroxyl radical-scavenging activity, showed more potent suppressive effect on substance P-induced pruritus in mice than oxatomide."3.83Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases. ( Fujiwara, N; Hasegawa, F; Inoue, Y; Isobe, M; Isobe, Y; Tobe, M; Tsuboi, K, 2016)
" Although topical corticosteroids have been widely utilized in steroid-responsive dermatoses such as AD, their chronic use may be associated with significant side effects."1.32Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses. ( Hayashi, H; Inoue, Y; Isobe, M; Shiohara, T, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tobe, M1
Tsuboi, K1
Hasegawa, F1
Fujiwara, N1
Inoue, Y2
Isobe, M2
Isobe, Y1
Shiohara, T1
Hayashi, H1
Potekaev, NS1
Sevidova, LIu2
Vladimirov, VV1
Kochergin, NG2
Shinaev, NN2
Belokrinitskiĭ, VV1
Shelepin, AA1

Other Studies

4 other studies available for uracil and Dermatitis, Atopic

ArticleYear
Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases.
    Bioorganic & medicinal chemistry letters, 2016, Feb-15, Volume: 26, Issue:4

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Benzofurans; Cell Line, Tumor; Cell Membran

2016
Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
    International archives of allergy and immunology, 2003, Volume: 131, Issue:2

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chronic Disease; Dermatitis, Atopic; Der

2003
[Selective phototherapy and immunocorrection with dimotsifon in atopic dermatitis].
    Vestnik dermatologii i venerologii, 1987, Issue:9

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Combined Modality Therapy; Dapsone; Dermatitis, Atopic; D

1987
[Therapeutic efficacy of dimocifon in atopic dermatitis].
    Vestnik dermatologii i venerologii, 1986, Issue:9

    Topics: Adolescent; Adult; Dapsone; Dermatitis, Atopic; Drug Combinations; Female; Humans; Male; Uracil

1986